Pharmaceutical and biotech companies
Delegate a complete early-phase study or specific activities: regulatory submissions, monitoring, project management, documentation.
See clinical trial servicesIndependent European CRO · Belgium, since 2005
CROPHA supports pharmaceutical, biotechnology and medical device companies, as well as other CROs, in conducting their clinical studies in Europe. From regulatory submissions and monitoring to project management and patient recruitment, we provide full or functional support tailored to each study. TEST-PROD

Independent Belgian CRO
Countries, sites and realistic recruitment potential.
Protocol, documentation, regulatory and ethics submissions.
Site and physician engagement to reach eligible patients.
Monitoring and project management by experienced local teams.
Close-out visits, data and final reporting with our partners.
Who we work with
Senior expertise and direct contact, without the overhead of a large organization.
Delegate a complete early-phase study or specific activities: regulatory submissions, monitoring, project management, documentation.
See clinical trial servicesPre- and post-market clinical investigations conducted in line with ISO 14155 and the EU MDR, from investigation plan to final report.
Extend your capacity with experienced monitors, functional services or patient recruitment support, on a flexible basis.

Full service
Phase I and II
Clinical trial services
CROPHA can take responsibility for an entire study or for selected activities, ensuring continuity across the critical stages of your trial.
Full-service delivery covers Phase I and II studies; functional services are available for other phases.Define your study scope
Planning, timelines, vendor coordination, risk management and sponsor reporting.
Site qualification, initiation, routine, remote and close-out visits in line with ICH-GCP, carried out by experienced local monitors.
Submissions to competent authorities and ethics committees, including under the CTR and MDR, and ongoing study maintenance.
Protocols, investigator brochures, study reports and clinical documentation.
Country and site feasibility, investigator identification and assessment of recruitment potential.
Recruitment strategy, site and physician engagement, and enrolment follow-up.
CRF design, data cleaning, statistical analysis plans and analysis, with CROPHA as your single point of contact and full oversight of deliverables.
Coordination of investigational product packaging and labelling.
Writing, review and translation of patient-facing and study documents.
Patient recruitment
Recruitment remains one of the main causes of delay in clinical research.

CROPHA helps sponsors, CROs and sites build realistic recruitment strategies from the feasibility stage onwards, adapted to the therapeutic area, the target population and the participating sites.
Estimating realistic enrolment before sites are selected.
Involving referring physicians and supporting sites throughout enrolment.
Tracking enrolment and adjusting the strategy early when targets are at risk.
Innovation in patient referral
Drawing on its operational experience, CROPHA is developing P-REFER-P, a physician-led referral approach designed to help clinical trials reach potentially eligible patients through their treating physicians.
Contact us to learn moreMedical devices
Clinical research support for medical device studies, conducted in line with ISO 14155 and European regulatory requirements.
About CROPHA
CROPHA is an experienced, flexible team supported by a network of experienced local professionals in Europe. Our senior staff remain directly involved in monitoring and study delivery, so the expertise you contract is the expertise working on your study.
Founder and Managing Director
Luc Moriau has 28 years of experience in clinical research, spanning clinical monitoring, project management and CRO leadership.
He founded CROPHA in 2005 to offer sponsors a flexible, responsive alternative combining operational rigour with a pragmatic approach to study delivery.

Making clinical research more efficient and better connected to patients. We combine operational experience, flexibility and innovation to help sponsors, CROs and sites run their studies effectively, and to address persistent challenges such as patient recruitment.
Training and resources
CROPHA's historical expertise in CRA development remains available to sponsors and CROs who need qualified, operational monitoring staff.
Group sessions of up to 12 participants at the APTASKIL Learning Centre in Seneffe, or on your premises.
On-the-job guidance after training.
Web-based evaluation of competencies and performance.
Secondment, outsourcing or permanent placement.

Training venue
APTASKIL Learning Centre, Seneffe
Up to 12 participants per session, or on your premises.
FAQ
Scope, timelines and service levels are confirmed in each proposal.
Yes. CROPHA provides full-service delivery for Phase I and II studies, and can also take on selected activities as functional services.
Full service covers Phase I and II. For other phases, CROPHA provides functional services such as monitoring, regulatory support or medical writing.
Yes. CROPHA supports pre- and post-market clinical investigations in line with ISO 14155 and the EU MDR.
CROPHA conducts clinical studies primarily in Europe. In each country, we work with experienced local teams who know the language, the regulatory environment and the investigational sites. Country coverage is confirmed for each project at the feasibility stage.
From feasibility onwards, we help build a realistic recruitment strategy, engage sites and referring physicians, and track enrolment so the strategy can be adjusted early.
Yes. Many projects combine CROPHA's functional services with a sponsor's or CRO's own teams.
These activities are carried out by trusted partners, coordinated by CROPHA, which remains your single point of contact.
Yes. GCP and ISO 14155 training, CRA coaching, assessment and resourcing remain available.
Contact
Tell us about your project, your timelines and where you need support. We will help you clarify the scope before you commit resources.